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Abstract
 
The B cell adaptor containing src homology 2 domain (BASH; also termed BLNK or SLP-65),
is crucial for B cell antigen receptor (BCR)-mediated activation, proliferation, and differentia-
tion of B cells. BCR-mediated tyrosine-phosphorylation of BASH creates binding sites for
signaling effectors such as phospholipase C
 
 
 
 (PLC
 
 
 
)2 and Vav, while the function of its
COOH-terminal src homology 2 domain is unknown. We have now identified hematopoietic
progenitor kinase (HPK)1, a STE20-related serine/threonine kinase, as a protein that inducibly
interacts with the BASH SH2 domain. BCR ligation induced rapid tyrosine-phosphorylation
of HPK1 mainly by Syk and Lyn, resulting in its association with BASH and catalytic activa-
tion. BCR-mediated activation of HPK1 was impaired in Syk- or BASH-deficient B cells. The
functional SH2 domain of BASH and Tyr-379 within HPK1 which we identified as a Syk-
phosphorylation site were both necessary for interaction of both proteins and efficient HPK1
activation after BCR stimulation. Furthermore, HPK1 augmented, whereas its kinase-dead
mutant inhibited I
 
 
 
B kinase 
 
 
 
 (IKK
 
 
 
) activation by BCR engagement. These results reveal a
novel BCR signaling pathway leading to the activation of HPK1 and subsequently IKK
 
 
 
, in
which BASH recruits tyrosine-phosphorylated HPK1 into the BCR signaling complex.
Key words: antigen receptor signaling • BCR • BLNK • SH2 domain • I
 
 
 
B kinase
 
Introduction
 
Stimulation of B cells through the B cell antigen recep-
tor (BCR)
 
*
 
 provokes, depending on their developmental
stage, such diverse responses as proliferation, differentia-
tion, cell-cycle arrest, or apoptosis. BCR signaling is initi-
ated by activation of cytoplasmic protein tyrosine kinases
(PTKs) including Src family kinases, Syk, and Btk. Acti-
vated PTKs then phosphorylate and enhance the enzymatic
activities of various signaling intermediates including phos-
pholipase C
 
 
 
 (PLC
 
 
 
)2, phosphoinositide 3-kinase, and
Vav, which in turn transmit the signals into distinct path-
ways leading to the activation of nuclear transcription fac-
tors such as AP-1, nuclear factor (NF)-AT, and NF-
 
 
 
B
(1–4). Distinct signaling pathways appear to be activated
selectively, depending on the developmental stage, activa-
tion state, or tolerance status of B cells and the nature of the
pertinent antigen (5, 6). However, it remains to be under-
stood how a receptor signals to several pathways and how
the specific pathways are selected.
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Abbreviations used in this paper:
 
 BASH, B cell adaptor containing SH2
domain; BCR, B cell antigen receptor; CBP, calmodulin-binding pro-
tein; ERK, extracellular signal–regulated kinase; HPK, hematopoietic
progenitor kinase; IKK
 
 
 
,
 
 
 
I
 
 
 
B kinase 
 
 
 
; MAPK, mitogen-activated pro-
tein kinase; MBP, myelin basic protein; NF, nuclear factor; PLC
 
 
 
, phos-
pholipase C
 
 
 
; PTK, protein tyrosine kinase; WT, wild-type. 
530
 
BASH Mediates BCR Activation of HPK1
 
A recently identified novel B cell–specific protein termed
B cell adaptor containing src homology 2 domain (BASH;
also known as BLNK or SLP-65) has been shown to be an
adaptor that plays a central role in BCR–signal transduction
(7–9). BASH is structurally and functionally related to the
adaptor protein SLP-76 of hematopoietic cells which serves
a crucial function in signal transduction from TCR, Fc
 
 
 
-,
and collagen-receptors in T cells, mast cells, and platelets
(10). BASH consists of an NH
 
2
 
-terminal acidic domain
containing tyrosine-based SH2 domain–binding motifs, a
central domain containing proline-rich motifs and a
COOH-terminal SH2 domain. After tyrosine phosphoryla-
tion primarily by Syk, BASH associates with PLC
 
 
 
, Vav,
and Btk through their SH2 domains, with Grb2 through its
SH2 and SH3 domains and with Nck and Syk. Shortly after
BCR stimulation, translocation of BASH to the membrane
fraction of cells can be observed. The NH
 
2
 
-terminal and
the central domains of BASH are presumably the binding
sites for the aforementioned SH2 and SH3 domain–con-
taining proteins, whereas the binding partners of the
COOH-terminal SH2 domain remain unknown (7–9, 11–
13). Experiments using normal or BASH/BLNK-deficient
B cell lines indicated that BASH mediates phosphorylation
and activation of PLC
 
 
 
2 by Syk and Btk, elevation of in-
tracellular calcium concentration ([Ca
 
2
 
 
 
]i), NF-AT activa-
tion, and activation of mitogen-activated protein kinases
(MAPKs), extracellular signal–regulated kinase (ERK),
JNK, and p38, after BCR engagement (7, 12, 13). Thus,
BASH is proposed to function as a scaffold protein for vari-
ous signaling effectors and to recruit them into a BCR sig-
naling complex containing PTKs at the plasma membrane.
Targeted disruption of the BASH gene in mice resulted in a
partial block of early B cell development, absence of mature
B and peritoneal B-1 cells, defective activation and prolifer-
ation of B cells upon BCR ligation in vitro, decreased se-
rum Ig levels, and impaired T cell–independent immune
responses. This phenotype can be ascribed to BCR and
pre-BCR signaling deficiencies (14–17).
In an alternative approach to understand the mechanism
how BASH mediates BCR signal transduction, we have
searched for proteins that interact with the SH2 domain of
BASH after BCR stimulation. Here we report the identifi-
cation of hematopoietic progenitor kinase (HPK)1 as a
BASH SH2 domain–associated protein. HPK1 is a hemato-
poietic cell-specific serine/threonine kinase and belongs to
the GCK family of STE20-related kinases. The HPK1 ki-
nase domain which occupies the NH
 
2
 
-terminal third of the
protein is followed by four proline-rich motifs clustered in
a central region. Ectopic expression of HPK1 in fibroblasts
resulted in the activation of the JNK/SAPK MAPKs (18,
19) and I
 
 
 
B kinases (IKKs; reference 20). The upstream re-
ceptors and the mechanism of activation for HPK1 in he-
matopoietic cells are only starting to emerge. SH3 domain–
containing adaptor proteins such as Grb2, Crk, CrkL,
SH3P7/HIP-55, and HS1 have been shown to interact
with the proline-rich motifs of HPK1 (21–24). Recently,
Liou et al. have demonstrated that HPK1 is activated in re-
sponse to TCR and BCR engagement (25). This activation
 
is dependent, to various extents, on Src and Syk family
PTKs and the adaptor proteins LAT, SLP-76, BLNK/
BASH, Grb2, and Grap. This study also indicated that
HPK1 is a negative regulator for the ERK pathway in
TCR signaling. Furthermore, Liu et al. demonstrated acti-
vation of HPK1 in response to TCR stimulation and sub-
sequent binding to Grb2-related adaptor Gads (26).
Here we present a mechanistic model that links BCR
stimulation to the activation of HPK1 in B cells. Our data
suggest that BCR activation induces phosphorylation of
HPK1 on tyrosine-379, which then results in binding of
HPK1 to the SH2 domain of BASH. We have also demon-
strated that HPK1 does not affect ERK activation, but no-
tably upregulates I
 
 
 
B kinase 
 
  
 
(IKK
 
 
 
) activation in the
BCR signaling pathway.
 
Materials and Methods
 
Cells and Antibodies.
 
Stable transfectants of WEHI231 and its
subclone (WEHI231.5, a gift of Dr. T. Tsubata, Medical Re-
search Institute, Tokyo Medical and Dental University, Tokyo,
Japan) were maintained as described previously (27). Spleen cells
were prepared from C57BL/6 mice and the splenic B cells were
enriched by killing T cells with culture supernatant of hybridoma
T-24 (anti-Thy1 MoAb) and rabbit complement (16). WEHI231
and splenic B cells were stimulated with 10 
 
 
 
g/ml goat F(ab
 
 
 
)
 
2
 
fragment anti–mouse IgM Ab (
 
 
 
 chain specific; Jackson Immu-
noResearch Laboratories). Wild-type (WT) and Syk-, Lyn-, Btk-,
or BASH/BLNK-deficient DT40 cells (gifts of Drs. T. Kurosaki
and M. Ishiai, Institute for Liver Research, Kansai Medical Uni-
versity, Osaka, Japan) were maintained and stimulated with 25
 
 
 
g/ml anti–chicken IgM MoAb (M4) as described previously
(28, 29, 12). COS7 and 293T cells were cultured in DMEM sup-
plemented with 10% FCS and 50 
 
 
 
m 2-ME. Rabbit antisera
against HPK1 (amino acids 1–18, #2) or HPK1 (amino acids
811–825, #7) were used for immunoprecipitation and immuno-
blot analysis, respectively (21). Rabbit antiserum against BASH
(16) was used for immunoprecipitation, while goat Ab (anti-
BLNK, C-19, Santa Cruz Biotechnology, Inc.) was used for im-
munoblot analysis. mAbs against the T7 epitope, phosphotyrosine
(PY20), the HA epitope (12CA5), and the Flag epitope (M5)
were purchased from Novagen, Transduction Laboratories,
Boehringer Mannheim, and Sigma-Aldrich, respectively. Rabbit
anti-Lyn (44), anti-Syk (LR), anti-IKK
 
 
 
/
 
 
 
 (H-470), anti c-Rel
(C), and anti-SP1 (PEP2) Abs were from Santa Cruz Biotechnol-
ogy, Inc. Goat anti-GST Ab was from Amersham Pharmacia Bio-
tech. Control mouse IgG was from Zymed Laboratories.
 
Expression Constructs and Transfection.
 
Mouse BASH cDNA
(16) was truncated at a StuI site (BASH
 
 
 
SH2) or mutated
by PCR-based site-directed mutagenesis (Quickchange; Strat-
agene) to substitute Lys for Arg-373 in the SH2 domain
(BASH[R373K]). The mutated or WT BASH cDNAs were li-
gated in-frame with an NH
 
2
 
-terminal T7-epitope tag into
pAT7neo expression vector (30). WEHI231 cells were electropo-
rated (240 V, 900 
 
 
 
F) with either pAT7-BASH or pAT7-
BASH
 
 
 
SH2, selected with G418 (1.2 mg/ml), and stable clones
expressing exogenous BASH proteins at high level were estab-
lished. One of the selected clones expressing exogenous BASH
(B7) was further transfected with HPK1 expression vectors,
which are composed of pCAG-Puro vector (30) and either of the
inserts of pcDNA3-HPK1:HA or pcDNA3-HPK1(K46E):HA 
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(18), and selected with puromycin (1 
 
 
 
g/ml; Sigma-Aldrich) to
establish stable transfectants. pMT2-HPK1 was described previ-
ously (18). The insert of the pcDNA3-HPK1:HA was recloned
into pCAGGS expression vector (31) resulting in pCAGGS-
HPK1:HA. Mutation of HPK1 Tyr-379 into Phe in pcDNA3-
HPK1:HA gave rise to pcDNA3-HPK1(Y379F):HA. A BamHI
fragment of pcDNA3-HPK1:HA containing a COOH-terminal
part of HPK1 (residues 327–827) and an HA-epitope tag was in-
serted into a BamHI site of pGEX-3X (Amersham Pharmacia
Biotech) to make pGST-HPK1-C. pME-Lyn and pME-Syk
were described previously (32). Expression vectors for glu-
tathione S-transferase (GST)-I
 
 
 
B
 
 
 
 and Flag epitope-tagged
IKK
 
 
 
, respectively, were gifts of Dr. H. Nakano (Juntendo Uni-
versity, Tokyo, Japan; reference 33). pSR
 
 
 
-HA-MAPK encod-
ing Xenopus ERK2 and pGST-Elk1 were gifts of Drs. E. Nishida
(Kyoto University, Kyoto, Japan) and T. Kurosaki, respectively.
DT40 or DT40 mutant cells (5 
 
 
 
 10
 
6
 
 per 0.25 milliliter per cu-
vette) were transiently transfected with the indicated plasmids
(25–40 
 
 
 
g in total) by electroporation (975 
 
 
 
F, 240 V) and har-
vested after 36 h. COS7 or 293T cells (5 
 
 
 
 10
 
5
 
) were transfected
using a TransIT-LT1 transfection reagent (Pan Vera) and har-
vested after 36 h.
 
In Vitro Binding Assay with Calmodulin-binding Protein Fusion
Proteins.
 
Sequences corresponding to the SH2 domain (residues
341–457) of mouse BASH were amplified by PCR from BASH
and BASH (R373K) cDNAs and inserted into the pCAL-n-EK
prokaryotic expression vector, giving rise to a calmodulin-bind-
ing protein (CBP)–BASH SH2 domain fusion protein (Affinity
LIC cloning and protein purification kit; Stratagene). CBP fusion
proteins were purified with calmodulin affinity resins in binding
buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 2 mM CaCl
 
2
 
, 1
mM magnesium acetate). Anti-IgM–stimulated or unstimulated
WEHI231.5 cells (10
 
7
 
) were lysed in the binding buffer supple-
mented with 1% NP-40 and protease and phosphatase inhibitors
(1 mM PMSF, 10 
 
 
 
g/ml aprotinin, 10 
 
 
 
g/ml leupeptin, 5 mM
sodium orthovanadate, 10 mM NaF). The cell lysates were pre-
cleared with the CBP–SH2(R373K)-bound calmodulin affinity
resins (5 
 
 
 
g) then incubated with 2 
 
 
 
g of the purified CBP–SH2
(WT) or CBP–SH2 (R373K) fusion proteins immobilized on the
affinity resins for 1 h at 4
 
 
 
C. The resins were washed five times
with the binding buffer supplemented with 0.4% NP-40 and the
inhibitors and the bound proteins were subjected to SDS-PAGE
followed by immunoblot analysis.
GST and GST-HPK1-C proteins were produced in the re-
combinant bacterial strain TKB1 harboring an Elk tyrosine kinase
gene or the parental TK-deficient BL21(DE3) cells (Stratagene)
transformed with either pGEX-3X or pGST-HPK1-C, as fol-
lows. Recombinant protein expression was induced by 0.4 mM
isopropylthiogalactopyranoside and cells were sonicated in bacte-
rial lysis buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1 mM
DTT, 10 
 
 
 
g/ml aprotinin, 10 
 
 
 
g/ml leupeptin, 1 mM PMSF, 1
mM sodium orthovanadate). The lysates were cleared by centrif-
ugation at 12,000
 
 
 
 
 
g f
 
or 20 min and GST proteins were purified
on glutathione sepharose 4B (Amersham Pharmacia Biotech). Pu-
rified GST proteins (0.4 
 
 
 
g) were precleared and incubated in
binding buffer with resin-immobilized CBP–SH2 domain fusion
proteins (0.5 
 
 
 
g) in the presence of protease and phosphatase in-
hibitors, and the bound proteins were analyzed as above.
 
Immunoprecipitation, Immunoblot Analysis, and In Vitro Kinase
Assay.
 
For immunoprecipitations, cells were lysed on ice in lysis
buffer (1% NP-40, 50 mM Tris, pH 7.8, 150 mM NaCl, 2 mM
EDTA) containing protease and phosphatase inhibitors. Pre-
cleared lysates were incubated with appropriate Abs and protein
G-sepharose beads (4 Fast Flow; Amersham Pharmacia Biotech).
After extensive washing with lysis buffer (with 0.5% NP-40), the
immunoprecipitates were subjected to immunoblot analysis using
appropriate Abs, which were visualized using chemiluminescense
(ECL kit; Amersham Pharmacia Biotech). For in vitro
 
 
 
kinase as-
says, the washed immunocomplexes were divided into equal parts
and half of the precipitates was subjected to the kinase reaction
while the other half was subjected to immunoblotting to estimate
the amounts of precipitated proteins. For HPK1 kinase assays,
immunoprecipitates were washed three times with lysis buffer,
twice with TNE buffer (50 mM Tris, pH 7.6, 150 mM NaCl,
and 2 mM EDTA) and once with kinase buffer (50 mM Tris, pH
7.6, 8 mM MgCl
 
2
 
, 2 mM MnCl
 
2
 
, and 1 mM DTT). Autophos-
phorylation reactions were performed at 30
 
 
 
C for 20 min in the
kinase buffer (30 
 
 
 
l) containing 10 
 
 
 
Ci of [
 
 
 
-
 
32
 
P] ATP. For
transphosphorylation, 10 
 
 
 
g of myelin basic protein (MBP;
Sigma-Aldrich) were added as a substrate in the presence of 5 
 
 
 
M
of cold ATP. The reactions were stopped by addition of 5
 
 
 
 SDS
sample buffer, then samples were analyzed by SDS-PAGE, fol-
lowed by autoradiography of dried gels. IKK
 
 
 
 
 
kinase assays was
performed as described previously (20) with 5 
 
 
 
g of GST-I
 
 
 
B
 
 
 
protein as a substrate in the presence of 13 
 
 
 
M cold ATP. ERK2
kinase assay was performed as described previously (34).
Nuclear extracts were prepared as follows: 4 
 
 
 
 10
 
6
 
 cells per
sample were resuspended in 150 
 
 
 
l buffer A (10 mM Hepes, pH
7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT,
and protease/phosphatase inhibitors) and placed on ice for 15
min. NP-40 (0.6% final) was added to the cell suspensions, which
were then mixed vigorously for 10 s and centrifuged at 12,000
rpm for 1 min. The nuclear pellet was washed three times with
buffer A and extracted with 50 
 
 
 
l buffer C (20 mM Hepes, pH
7.9, 25% glycerol, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA, 1
mM DTT, and protease/phosphatase inhibitors) by vigorous agi-
tation for 15 min at 4
 
 
 
C. The extracts were cleared by centrifuga-
tion for 5 min and the supernatants (20 
 
 
 
l per lane) were sub-
jected to SDS-PAGE, followed by immunoblot analysis.
All data shown are representative of two to four independent
experiments with essentially identical results.
 
Results and Discussion
 
BCR-induced Tyrosine-Phosphorylation of HPK1 and its
Binding to the BASH SH2 Domain.
 
To identify proteins
interacting with the SH2 domain of BASH, lysates of
WEHI231 B lymphoma cells either unstimulated or after
BCR ligation were first incubated with CBP fused to a
nonfunctional mutant of the BASH SH2 domain (CBP-
SH2[R373K]) to absorb nonspecific-binding proteins. Un-
bound material was then tested for its ability to bind to a
CBP-fusion protein containing the WT BASH SH2 do-
main. Among the bound proteins, tyrosine-phosphorylated
species were identified by antiphosphotyrosine immuno-
blotting (Fig. 1 A, top). Two phosphoproteins of an ap-
proximate molecular weight of 100 and 74 kD were found
to specifically interact with the WT BASH SH2 domain
only after BCR stimulation (lanes 1 and 2). Very little phos-
phoprotein interacted with the mutant SH2 domain, indi-
cating high efficiency of the preabsorption procedure (lanes
3 and 4). Testing with various antibodies directed against
known signaling entities identified the 100-kD phospho- 
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protein as the HPK1 (Fig. 1 A, bottom), while the identity
of the 74-kD protein remains to be determined.
To address whether the interaction of BASH and HPK1
occurs at endogenous expression levels in vivo, WEHI231
cells and purified splenic B cells were treated with anti–
IgM Ab, and lysed. Then the cell lysates were subjected to
immunoprecipitation with anti-BASH antiserum or irrele-
vant antiserum as a negative control, and subsequently im-
munoblotted with anti-HPK1 antiserum (Fig. 1 B). In both
cell types, HPK1 clearly coprecipitated with BASH and the
amount of the precipitated HPK1 was markedly increased
3 min after BCR stimulation (lanes 1–4, 13, and 14). To
confirm that the endogenous interaction between BASH
and HPK1 is mediated through the SH2 domain of BASH,
stably transfected WEHI231 cells expressing either T7
epitope-tagged WT BASH (T7-BASH) or a truncated
form lacking the SH2 domain (T7-BASH
 
 
 
SH2) were sub-
jected to anti-T7 immunoprecipitation. As shown in Fig. 1
C, endogenous HPK1 coprecipitated with T7-BASH and
again a marked enhancement of the interaction was ob-
Figure 1. Direct binding of tyrosine phosphorylated HPK1 to the SH2 domain of BASH in response to BCR stimulation. (A) BCR engagement in-
duced binding to the BASH SH2 domain in vitro of phosphoproteins including HPK1. WEHI231.5 cells were stimulated for 3 min with anti–IgM
F(ab )2 fragment ( ) or left unstimulated ( ). Lysates from these cells were precleared through binding to beads coupled with recombinant CBP fusion
proteins of mutated (R373K) BASH SH2 domain, then incubated with the beads with the fusion proteins of the WT (lanes 1 and 2) or mutated (R373K)
BASH SH2 domain (lanes 3 and 4). Bound material was eluted from the fusion protein, separated by SDS-PAGE, and subjected to immunoblotting with
antiphosphotyrosine (anti-pY) Ab (top). Subsequently, the membrane was reprobed with anti-HPK1 #7 Ab (bottom). Whole cell lysates were included
for visualization of all tyrosine-phosphorylated proteins (lanes 5 and 6). (B) Interaction of endogenous BASH with HPK1 in B cells. WEHI231.5 (1.5  
107) or splenic B cells (6.8  107) were stimulated with anti–IgM F(ab )2 fragment for the indicated periods of time (min). Lysates from these cells were
immunoprecipitated (IP) with rabbit anti-BASH serum (lanes 1–4, 13, and 14) or control antiserum against MIST peptide (unpublished data; lanes 5–8
and 15), separated on SDS-PAGE, and then immunoblotted with anti-HPK1 #7 Ab (top). The same membranes were reprobed with anti-BASH (C-19)
Ab to visualize the immunoprecipitated BASH proteins (bottom). The presence of HPK1 in whole cell lysates was ascertained by immunoblotting with
the anti-HPK1 #7 Ab (lanes 9–12, 16, and 17). (C) In vivo interaction of HPK1 and BASH is dependent on the BASH SH2 domain. Stably transfected
WEHI231 cells (107) expressing either T7 epitope–tagged WT BASH (T7-BASH) or a BASH SH2 domain truncation mutant (T7 BASH SH2) were
stimulated with anti–IgM F(ab )2 fragment for the indicated periods of time (min). Lysates from these cells were immunoprecipitated with either anti-T7
Ab or control mouse IgG (mIgG), and the precipitates were immunoblotted with anti-HPK1 #7 Ab (top), then reprobed with anti-T7 Ab (middle).
Anti-HPK1 immunoblotting of the lysates demonstrated comparable levels of HPK1 proteins between the transfectants (bottom). (D) Binding of recom-
binant HPK1 to the BASH SH2 domain depends on HPK1 tyrosine phosphorylation. GST and GST-HPK1-C proteins produced in bacterial strains
containing ( ) or not containing ( ) an active PTK were affinity purified and incubated with immobilized CBP-BASH SH2 domain fusion proteins (as
described in A). Bound proteins were eluted and immunoblotted with anti-GST (top, lanes 3–6), anti-HPK1 #7 (top, lanes 7–10), and anti-pY (bottom)
Abs. One-twenty-seventh of the GST fusion proteins subjected to the binding reaction was loaded on the same gel (“input,” lanes 1, 2, 11, and 12). The
electrophoretic mobility of GST and GST-HPK1-C proteins is indicated.533 Tsuji et al.
served after BCR ligation (lanes 3–5). HPK1 failed to in-
teract with the BASH SH2 mutant (lanes 8–10). These re-
sults indicate that BASH forms a complex with HPK1
through its SH2 domain in B cells, which is strongly and
transiently enhanced upon BCR engagement.
To determine whether the interaction of HPK1 and the
BASH SH2 domain is direct, we prepared a GST fusion
protein encompassing the noncatalytic domain of HPK1
(residues 327–827) from Escherchia coli in tyrosine-phos-
phorylated and nonphosphorylated form (see Fig. 1 D,
lanes 11 and 12) and repeated the pull-down assay de-
scribed above with these reagents. GST-HPK1 was bound
to the BASH SH2 domain, which was dependent on tyro-
sine-phosphorylation (lanes 7 and 8), while no binding to
the nonfunctional SH2 domain mutant (R373K) was ob-
served (lanes 9 and 10). A control GST protein was bound
to neither of the SH2 domains (lanes 3–6). These results
clearly indicate a direct interaction between tyrosine-phos-
phorylated HPK1 and the SH2 domain of BASH.
We next examined whether BCR stimulation induces
HPK1 tyrosine-phosphorylation and if this phosphoryla-
tion is mediated by BCR-associated PTKs. In WEHI231
cells, BCR engagement markedly induced tyrosine phos-
phorylation of endogenous HPK1 peaking at 3 min after
BCR ligation (Fig. 2 A). The same kinetics of HPK1 phos-
phorylation was observed in WEHI279 cell, an indepen-
dent B cell lymphoma (data not shown). In addition, tran-
siently expressed HPK1 was also tyrosine-phosphorylated
in DT40 chicken B cells, the level of which was greatly
augmented by BCR ligation (Fig. 2 B, first panel). BCR-
induced HPK1 phosphorylation was undetectable in Syk-
deficient DT40 cells, greatly reduced but detectable in
Lyn-deficient DT40 cells and unaffected in Btk- or BASH-
deficient DT40 cells. This result indicates that Syk is essen-
tial for BCR-induced tyrosine-phosphorylation of HPK1,
and that Lyn strongly upregulates the HPK1 tyrosine phos-
phorylation level presumably through augmenting the cata-
lytic activity of Syk (35) or by direct phosphorylation of
HPK1 which would then be dependent on a preceding
phosphorylation by Syk (36).
In contrast to our results, Liou et al. detected no tyrosine-
phosphorylation on HPK1 in response to TCR stimulation
(25). Very recently, Liu et al. have demonstrated HPK1 ty-
rosine-phosphorylation in a murine T cell hybridoma after
TCR activation (26). Thus, the extent of HPK1 tyrosine
phosphorylation upon antigen receptor stimulation may
substantially differ among lymphoid cell types.
Transient expression of either Lyn or Syk in COS7 cells
resulted in tyrosine-phosphorylation of HPK1 (Fig. 3 A,
lanes 2 and 3), although Lyn was not able to phosphorylate
HPK1 in the absence of Syk in DT40 cells after BCR liga-
tion (Fig. 2 B). This result likely reflects a deregulated ki-
nase activity of Lyn and possibly a relaxed dependence on
compartmentalization in this overexpression system (Fig. 3
A, lane 3; unpublished data). To examine whether the
PTK-mediated phosphorylation of HPK1 is involved in its
association with BASH, expression vectors for HPK1,
BASH, and either Lyn or Syk were cotransfected into
COS7 cells, and binding of HPK1 to BASH was deter-
mined by immunoprecipitation analysis (Fig. 2 C). When
coexpressed with Lyn or Syk, a considerable amount of
tyrosine-phosphorylated HPK1 coprecipitated with WT
BASH (Fig. 2 C, left, lanes 3 and 4). Minimal coprecipita-
tion of HPK1 in the absence of exogenous PTKs was prob-
ably due to phosphorylation by undefined PTKs present in
COS7 cells (Fig. 2 C, left, lane 2). No binding of HPK1 to
Figure 2. BCR-mediated tyrosine-phosphorylation
of HPK1 and its effect on interaction with BASH. (A)
HPK1 is phosphorylated on tyrosine after BCR en-
gagement. WEHI231 cells (107) were stimulated with
anti–IgM F(ab )2 fragment for the indicated periods of
time (min) and HPK1 was immunoprecipitated with
anti-HPK1 #2 Ab. The precipitates were immunoblot-
ted with anti-pY Ab (top) and reprobed with anti-
HPK1 #7 Ab (bottom). (B) BCR-mediated phosphor-
ylation of HPK1 in PTK- or BASH-deficient DT40
cell lines. 1.5   107 WT or mutant DT40 cells were
transiently transfected with 75  g pCAGGS-HPK1:HA.
After 36 h, the cells were stimulated with anti–chicken
IgM Ab for the indicated periods of time (min). HA-
tagged HPK1 proteins were immunoprecipitated with anti-HA Ab and immunoblotted with anti-pY Ab (top), then reprobed with anti-HA Ab (bottom).
(C) Tyrosine-phosphorylation of HPK1 is required for the association of HPK1 with BASH. pMT2-HPK1 (2  g) and either (1  g) of pAT7-BASH,
pAT7-BASH(R373K), or empty vector pAT7 (mock) were cotransfected transiently with either (2  g) of pME-Lyn, pME-Syk, or empty vector pME
(mock) into COS7 cells. The cells were lysed and BASH proteins were immunoprecipitated using anti-T7 Ab. One-half of the precipitate was immuno-
blotted using anti-HPK1 #7 (top), while the other half was immunoblotted with anti-pY Ab (left, upper middle), then reprobed with anti-T7 Ab (left,
lower middle; right, middle). Equal HPK1 expression levels were visualized by immunoblotting of the cell lysates with anti-HPK1 #7 Ab (bottom).534 BASH Mediates BCR Activation of HPK1
the BASH SH2 domain mutant BASH (R373K) was de-
tected irrespective of the presence of Lyn and Syk (Fig. 2
C, right, lanes 6 and 7; compare to lanes 3 and 4). These
results indicated that PTK-mediated phosphorylation is a
prerequisite for the interaction of HPK1 with the BASH
SH2 domain.
To further characterize the interaction between HPK1
and BASH, we next aimed to identify the relevant phos-
phorylation site within HPK1 that mediates binding to the
BASH SH2 domain. A possible site was Tyr-379 located
within a DDDYDDV motif (residues 376–382) just NH2-
terminal of the second proline-rich region of HPK1. The
sequence context of this motif resembles an ExDYEDV se-
quence within the HS1 protein that has previously been
demonstrated to be an excellent substrate for Syk kinase
and upon phosphorylation a binding site for the SH2 do-
mains of Src family PTKs (37, 38). Upon coexpression in
COS7 cells, Syk failed to phosphorylate a HPK1 mutant
(HPK1[Y379F]) in which Tyr-379 was substituted by Phe
(Fig. 3 A, top, compare lanes 2 and 5; note that Syk expres-
sion [bottom] and total protein phosphorylation in the
lysate [lower middle] are equivalent). This indicates that
Tyr-379 is a major target site of Syk phosphorylation. Lyn-
mediated phosphorylation of HPK1 was apparently not af-
fected by the Y379F mutation, possibly because multiple
tyrosine residues in HPK1 are phosphorylated by Lyn (Fig.
3 A, lanes 3 and 6). In contrast to WT HPK1 (Fig. 3 B,
lanes 3 and 4), HPK1(Y379F) was not bound to BASH in
transfected COS7 cells, even when coexpressed with Lyn
or Syk (Fig. 3 B, lanes 7 and 8). These results indicate that
Tyr-379 within HPK1 is essential for binding to BASH and
thus strongly suggest that the DDDYDDV sequence con-
taining the phosphorylated Tyr-379 is the binding site for
the BASH SH2 domain. It has been shown that the similar
motifs, QEVYDDV and DEVYDDV of the FYB/SLAP
protein, are selectively phosphorylated on tyrosine by Fyn-T
kinase. The tyrosine phosphorylated version mediates bind-
ing to the SLP-76 SH2 domain which is closely related to
the SH2 domain of BASH (39, 40). Taken together with
our result, the phosphopeptide pYDDV is likely to be a
specific SH2 domain ligand of SLP family proteins.
BCR-induced Activation of HPK1 through Tyrosine-Phos-
phorylation and Binding to BASH SH2 Domain. The find-
ing that BCR engagement induces tyrosine-phosphoryla-
tion of HPK1 and its binding to BASH prompted us to
investigate whether the association with BASH contributes
to the activation of HPK1. First, we examined whether en-
dogenous HPK1 is activated by BCR engagement. In
WEHI231 (Fig. 4 A) and WEHI279 cells (data not shown),
HPK1 kinase activity was markedly elevated after BCR li-
gation, as assessed in vitro by both autophosphorylation and
transphosphorylation of a substrate protein. The kinetics of
HPK1 activation mirrored that of tyrosine-phosphorylation
shown in Fig. 2 A, suggesting that PTK-mediated phos-
phorylation is involved in the upregulation of HPK1 activ-
ity during BCR signaling. The kinetics of BCR-mediated
activation of transiently expressed HPK1 was roughly as-
sessed in WT and various PTK-deficient DT40 mutants
cells (Fig. 4 B). In DT40 cells, HPK1 kinase activity was
clearly elevated after BCR ligation, as recently reported by
Liou et al. (25). BCR-mediated HPK1 activation was ab-
sent from Syk-deficient cells, while in Btk-deficient cells it
was comparable to WT DT40 cells, indicating that Syk,
but not Btk, is essential for HPK1 activation. In Lyn-defi-
cient cells, HPK1 activation was delayed but reached a sig-
nificant level during the later phase of BCR stimulation.
Together with the observation that a very low level of
HPK1 tyrosine-phosphorylation was induced in Lyn-defi-
cient cells (Fig. 2 B), this suggested that Lyn-mediated mas-
sive phosphorylation was not essential for BCR-mediated
HPK1 activation but facilitated HPK1 activation.
In BASH-deficient DT40 cells, the BCR-mediated
HPK1 activation was substantially reduced (Fig. 4 B), al-
though its tyrosine-phosphorylation level was comparable
to that in WT DT40 cells (Fig. 2 B). Therefore, BASH
contributed greatly to the activation, but not to the ty-
rosine-phosphorylation, of HPK1 by BCR. To determine
the role of the SH2 domain of BASH in the activation of
HPK1, BASH-deficient cells were transiently reconstituted
with either WT BASH or its SH2 domain-mutant, BASH
(R373K), and BCR-mediated activation of cotransfected
HPK1 was measured by in vitro kinase assay. As shown in
Figure 3. Phosphorylation at Tyr-379 within HPK1 is essential for its
interaction with BASH. (A) Tyr-379 within HPK1 is a Syk-phosphoryla-
tion site. pcDNA-HPK1:HA or pcDNA-HPK1(Y379F):HA (1.2  g
each) was cotransfected transiently with pME-Lyn, pME-Syk, or empty
vector (mock) (2.4  g each) into COS7 cells. HPK1 proteins were im-
munoprecipitated with anti-HA Ab and immunoblotted with anti-pY
(top), then reprobed with anti-HPK1 #7 Ab (upper middle). Whole cell
lysates were immunoblotted with anti-pY Ab (lower middle) and anti-
Syk plus anti-Lyn Abs (bottom) to visualize expression of the PTKs. (B)
Tyr-379 is essential for binding HPK1 to BASH. HPK1(WT) or
HPK1(Y379F) was coexpressed transiently with T7-BASH and either
Lyn or Syk in COS7 cells. BASH was immunoprecipitated, and copre-
cipitated HPK1 proteins were analyzed as described in Fig. 2 C.535 Tsuji et al.
Fig. 4 C, WT BASH restored the activation of HPK1 by
the BCR (lanes 5 and 6), while BASH (R373K) did not
(lanes 7 and 8), indicating that a functional SH2 domain
is a prerequisite for BASH-mediated HPK1 activation.
Furthermore, the Syk phosphorylation–deficient mutant
HPK1 (Y379F) was barely activated in DT40 cells after
BCR ligation (Fig. 4 D). When expressed in 293T cells,
spontaneous kinase activity of HPK1(Y379F) was compa-
rable to that of WT HPK1, in contrast to that of a kinase-
dead mutant of HPK1 (K46E), indicating that the Y379F
mutation did not affect the intrinsic kinase activity of
HPK1 (Fig. 4 E). Taken together, these data indicated that
the BCR-induced activation of HPK1 is largely dependent
on binding to the BASH SH2 domain, which is mediated
by Tyr-379 after inducible phosphorylation by Syk.
Although our results clearly indicated that BASH medi-
ates, through direct interaction, the activation of HPK1 af-
ter BCR ligation, the exact mechanism for this observation
remains to be elucidated. Many protein kinases are known
to be activated by translocation to the plasma membrane,
and BASH has been shown to translocate to the membrane
after BCR stimulation (7). Therefore, it is tempting to
speculate that BASH mediates the translocation of HPK1
to the plasma membrane, where activation of HPK1 kinase
takes place. However, we found a substantial amount of
HPK1 protein constitutively associated with the membrane
fraction of WEHI231 cells which was independent of BCR
stimulation (data not shown). Therefore, BCR-induced
activation of HPK1 is not likely to result from membrane
translocation of HPK1. It is equally unlikely that BASH
brings HPK1 close to the BCR-associated PTKs for activa-
tion, because BCR-induced tyrosine-phosphorylation of
HPK1 was not abrogated in the absence of BASH (Fig. 2
B). Alternatively, binding of the BASH SH2 domain to
Y379 of HPK1 may cause a conformational change, which
leads to the activation of the kinase. Another possibility
would be that BASH recruits an unknown enzyme to
HPK1 which modifies HPK1 to become active. Further
studies are necessary to test these possibilities.
While our results indicated that BASH greatly contrib-
utes to the activation of HPK1 during BCR signaling,
HPK1 activation was not completely abolished in the ab-
sence of BASH (Fig. 4, B and C). In line with this notion,
we observed a weak activation of HPK1(Y379F), a mutant
Figure 4. BCR-induced activation of HPK1 is largely dependent on its interaction with BASH. (A) HPK1 kinase is activated in response to BCR
stimulation. WEHI231 cells (5   106) were stimulated with anti–IgM F(ab )2 fragment for the indicated periods of time (min). Cells were lysed, HPK1
was immunoprecipitated using anti-HPK1 #2 Ab, and its in vitro kinase activity was determined. Reaction products were separated by SDS-PAGE and
visualized by autoradiography. HPK1-autophosphorylation (top) and its kinase activity toward the exogenous substrate MBP (middle) are shown. Precip-
itated HPK1 proteins were visualized by immunoblotting with anti-HPK1 #7 Ab (bottom). (B) Activation of HPK1 in WT and mutant DT40 cells. WT
or various mutant DT40 cell lines (1.5   107 cells each) were transfected with pCAGGS-HPK1:HA (75  g) and stimulated with anti–chicken IgM Ab.
HA-tagged HPK1 proteins were immunoprecipitated using anti-HA Ab and their in vitro kinase activities toward MBP were determined as described in
A (top). Precipitated HPK1 was visualized by immunoblotting with anti-HA Ab (bottom). (C) The BASH SH2 domain mediates BCR-induced HPK1
activation. WT and BASH-deficient (BASH ) DT40 cells were transiently transfected with pCAGGS-HPK1:HA (30  g) in combination with 60  g of
either T7-BASH, T7-BASH (R373K), or empty vector (mock). Transfected cells were either left unstimulated ( ) or stimulated with anti–chicken IgM
Ab for 3 min ( ) and lysed. HPK1 was immunoprecipitated using anti-HA Ab and subjected to an in vitro kinase assay (top) and immunoblotting (mid-
dle) as described in B. BASH protein expression levels were visualized by immunoblotting of the lysates with anti-T7 Ab (bottom). (D) Tyr-379 is critical
for activation of HPK1 by BCR stimulation. DT40 cells were transfected transiently with pcDNA3-HPK1:HA or pcDNA3-HPK1(Y379F):HA vector
(75  g each). Cells were stimulated and HPK1 kinase activity was assayed as in B. (E) Spontaneous kinase activity of ectopically expressed HPK1(Y379F)
is comparable to WT HPK1. pcDNA3-HPK1:HA, pcDNA3-HPK1(Y379F):HA, or pcDNA3-HPK1(K46E):HA DNA (3  g each) was transfected into
293T cells and kinase activity of HPK1 was assayed as described in B.536 BASH Mediates BCR Activation of HPK1
that fails to associate with BASH, after BCR ligation (Fig. 4
D). Therefore, BASH-independent pathways leading to
HPK1 activation are likely to exist. Liou et al. reported a
notable reduction, although not entire abrogation, of
BCR-mediated HPK1 activation in DT40 cells lacking the
two mutually related adaptor proteins Grb2 and Grap, indi-
cating that Grb2 and Grap redundantly contribute to
BCR-mediated activation of HPK1 (25). In support of this
observation, previous reports demonstrated binding of the
Grb2 SH3 domains to proline-rich motifs within the
HPK1 hinge region (21, 22). Taken together, these data
imply that BASH and Grb2/Grap adaptors are indepen-
dently able to activate, albeit not fully, HPK1 and that both
adaptor types may act synergistically to achieve efficient
HPK1 activation. In addition, Grb2 was shown to associate
with BASH through either its SH2 or SH3 domains (8,
11). In summary, it is possible that HPK1, BASH, and
Grb2/Grap upon BCR stimulation form a trimolecular
complex which might result in the efficient activation of
HPK1 in a physiological context in B cells.
HPK1 Is a Positive Regulator of IKK  Activation by BCR.
Previous reports have demonstrated that ectopic expression
of HPK1 results in the activation of JNK/SAPK and IKKs
in fibroblasts (18–20) and of NF- B in T cells, myeloid pro-
genitors, and epithelial cells (41). Liou et al. demonstrated
that HPK1 is a negative regulator of TCR-induced ERK2
and AP-1 activation in T cells (25). To characterize the
downstream effectors of HPK1 in BCR signaling, we ex-
amined the effect of HPK1 overexpression in DT40 cells on
BCR-induced activation of such kinases. The activation
states of the transiently expressed kinases were determined
by in vitro kinase activities towards specific substrate pro-
teins. The activity of exogenous ERK2 was markedly in-
duced by anti–IgM Ab stimulation in DT40 cells, but was
unaffected by the presence of exogenous WT or kinase-
dead HPK1 (Fig. 5 A), even when the cells were stimulated
suboptimally (1, 3, or 10  g/ml of anti–IgM Ab, data not
shown). Therefore, HPK1 is unlikely to play a major role in
the regulation of ERK activity in response to BCR signal-
ing, which is in contrast to its reported effect on TCR sig-
naling. We failed to detect any induction of the kinase ac-
tivity of exogenous JNK towards a GST-c-Jun fusion
protein substrate after BCR ligation or stimulation with
PMA plus ionomycin in our transient DT40 cell expression
system (data not shown), although endogenous JNK has
been shown to be activated by the same stimuli in DT40
cells (34, 42). Thus, the involvement of HPK1 in BCR-
mediated JNK activation remains to be clarified.
It has recently been reported that the IKK complex is ac-
tivated by anti–IgM Ab stimulation of primary B cells (43).
We have observed BCR-mediated activation of the endog-
enous IKK complex in a mouse B cell line, BAL-17. While
we barely detected the activation of transfected exogenous
IKK  in BAL-17 cells and DT40 cells (data not shown),
we could readily detect BCR-induced activation of IKK 
upon transfection in these cell lines. BCR-dependent
IKK  activation was strongly enhanced by transfection of
WT HPK1, while basal level IKK  activity was un-
changed. On the contrary, a kinase-dead mutant of HPK1,
HPK1(K46E), potently inhibited BCR-induced IKK  ac-
tivation (Fig. 5 B, left; data not shown). In addition, the
noncatalytic COOH-terminal part of HPK1 (HPK1- N)
Figure 5. HPK1 positively regulates BCR-
induced IKK  activation. Expression vector (40  g)
for HA-epitope tagged ERK2 (A) or Flag-epitope
tagged IKK  (B) and either 40  g of pcDNA-
HPK1:HA (HPK[WT]), pcDNA-HPK1(K46E):HA
[HPK(K46E)], pCAT7-HPK1- N (HPK1- N)
(41), or empty vector (mock) were cotransfected
into DT40 cells (107). After stimulation with anti–
IgM Ab for the indicated periods of time (min), ex-
ogenous ERK2 (A) or IKK  (B) were immunopre-
cipitated with antibodies directed against their corresponding tags and their catalytic activities were measured in vitro using the specific substrate proteins,
GST-Elk1 (A) or GST-I B  (B), respectively (top). The amount of the precipitated kinases was estimated by immunoblotting with anti-HA Ab (A,
middle), anti-IKK  Ab (B, middle, left), or anti-Flag Ab (B, middle, right). Expression levels of HPK1 proteins were visualized by immunoblotting with
anti-HA Ab (bottom panels in A and B, left) or anti-HPK1 #7 Ab (B, bottom, right). In A, HA-epitope tagged HPK1 was also immunoprecipitated with
ERK2. However, we confirmed that HPK1 is unable to phosphorylate GST-Elk1 as assessed in a separate in vitro kinase assay (data not shown). (C) Nu-
clear extracts were prepared from anti-IgM–stimulated (1 or 2 h) or unstimulated (0) cells of WEHI231, a WEHI231-stable transfectant highly expressing
T7-tagged BASH (B7), B7-stable transfectants highly expressing either WT HPK1 (WT4-10 and WT5-32), or HPK1(K46E) (KE5-50 and KE5-58), and
subjected to immunoblot analysis with anti-c-Rel antibody (top). A part of the blot was probed with anti-SP1 antibody to control for the amount and in-
tegrity of the nuclear extracts used (bottom).537 Tsuji et al.
potently inhibited BCR-induced IKK  activation in DT40
cells (Fig. 5 B, right). The HPK1 COOH terminus has re-
cently been shown to inhibit NF- B activation via the
IKK complex in a dominant negative fashion (41). These
results strongly suggest that HPK1 is a physiological posi-
tive regulator of BCR-mediated activation of IKK com-
plex. This function is dependent on HPK1 kinase activity
and is most likely mediated by molecular interactions of its
COOH-terminal part.
It is known that activation of the IKK complex results in
the phosphorylation of specific serine residues, subsequent
ubiquitination, and proteasome-dependent proteolysis of
I B. NF- B/Rel proteins liberated from I B then translo-
cate to the nucleus and function as a transcription factor. In
WEHI231 cells, it was previously shown that NF- B/Rel
(a p50-c-Rel dimer) continuously translocates to the nu-
cleus, as the result of serine-phosphorylation– and protea-
some-independent, constitutive proteolysis of I B  (44).
Thus, we observed constitutively nuclear c-Rel and only
little increase of c-Rel in the nucleus after 1 h stimulation
by BCR ligation in WEHI231 cells (Fig. 5 C, lanes 1–3).
We found that overexpression of BASH in WEHI231 cells
resulted in an enhancement of the BCR-induced nuclear
accumulation of c-Rel (lanes 4–6). The BASH-mediated
c-Rel nuclear accumulation was inhibited by overexpres-
sion of HPK1(K46E) (lanes 13–18) but not by WT HPK1
(lanes 7–12). This result suggests that BCR-induced nuclear
translocation of c-Rel is upregulated by BASH through ki-
nase activity of HPK1 and is consistent with our results indi-
cating that HPK1 mediates BCR-induced IKK  activation.
Collectively, we have identified a role of HPK1 in a se-
lected signaling pathway leading to the IKK activation
downstream of the BCR, which underscores the functional
significance of HPK1 activation in BCR signal transduc-
tion. Obviously, further studies are needed to identify the
direct target of HPK1 in the IKK activation pathway.
Concluding Remarks. Here we provide evidence for an
inducible interaction between the BASH SH2 domain and
tyrosine-phosphorylated HPK1 in response to BCR liga-
tion in vitro and in vivo. The interaction was dependent
on tyrosine phosphorylation of HPK1 at a Syk consensus
phosphorylation site (Tyr-379) and the presence of a func-
tional BASH SH2 domain, both of which were also a pre-
requisite for the full BCR-mediated activation of HPK1
kinase activity. Our results are consistent with the results of
a study which demonstrated an interaction of BLNK/
BASH and HPK1 using a Syk-driven yeast two-hybrid sys-
tem. The interaction was dependent on Syk kinase activity,
a functional BLNK/BASH SH2 domain, and Tyr-379 of
HPK1 (personal communication by K. Sauer et al.). In ad-
dition, in vivo SLP-76 interacted with HPK1 in T cells.
TCR-mediated full activation of HPK1 in Jurkat T cells
required the presence of an intact SLP-76 SH2 domain and
Tyr-379 of HPK1 (personal communication). Together,
these results indicate that HPK1 may be a common target
of the conserved SH2 domains of SLP family hematopoi-
etic adaptor proteins (including Clnk/MIST, references 45
and 46) in immunoreceptor signaling and reveal a novel
function of these adaptors.
It has previously been shown that, upon BCR stimula-
tion, tyrosine-phosphorylated BLNK/BASH interacts with
the SH2 domains of PLC 2 and Btk, and mediates PLC 2
activation and the resulting calcium signaling (12, 13). Re-
cently, it has been shown that Btk and PLC 2 are necessary
for BCR-induced degradation of I B , as well as nuclear
translocation and transcriptional activation of NF- B in
DT40 cells (43, 47, 48). Btk dependence of BCR-induced
IKK activation, I B  degradation, and nuclear transloca-
tion of NF- B was also demonstrated using Btk-deficient
mouse splenic B cells (43, 47). Taken together with our re-
sults, BASH mediates activation of two independent path-
ways downstream of the BCR through distinct intramo-
lecular sites; NH2-terminal phospho-tyrosine containing
motifs function in Btk-mediated PLC 2 activation, while
the SH2 domain accomplishes HPK1 activation. Both
pathways have now been shown to contribute to the acti-
vation of the IKK complex and NF- B. However, each
pathway can be activated independently by stimuli other
than BCR ligation, and each pathway targets multiple and
distinct downstream effectors. Therefore, BASH-mediated
simultaneous activation of the two pathways may be critical
for efficient linkage between BCR and IKK activation. In
addition, this type of dual regulation system may contribute
to the fine tuning of receptor signaling.
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